Adaptive RNA Delivery Systems for Specialized Immunization Needs

This inventive concept adapts RNA delivery systems for immunization to cater to specific, narrow markets or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions.

The original patent disclosed a composition for non-viral delivery of RNA for immunization, but it had limitations in terms of stability and efficacy in diverse environments. The new inventive concept addresses these limitations by introducing specialized RNA delivery systems tailored to specific operational environments.

The inventive concept comprises a system for immunizing animals in extreme weather conditions, comprising liposomes and mRNA molecules with enhanced stability in high-temperature environments. Additionally, it includes a method for delivering RNA to trigger multiple immune pathways in a high-security facility, a composition for immunizing animals in disaster relief situations, a system for immunizing animals in remote, hard-to-reach areas, and a method for delivering RNA to trigger multiple immune pathways in a cold-chain storage facility. These specialized RNA delivery systems incorporate modified nucleotides, 5′ cap nucleosides, and sequences that encode specific immunogens to ensure effective immunization in diverse environments.

The new claims introduce novel adaptations of the original RNA delivery system, including modified nucleotides for enhanced stability, specialized sequences for specific immunogens, and tailored compositions for unique operational environments. These adaptations provide a non-obvious solution to the problem of limited efficacy and stability in diverse environments.

Alternative embodiments of the inventive concept could include RNA delivery systems for immunizing animals in other specialized environments, such as space exploration or high-altitude areas. Variations could also include different types of immunogens, modified liposomes, or alternative RNA molecules.

The inventive concept has significant commercial potential in industries such as biotechnology, pharmaceuticals, and veterinary medicine, particularly in areas with high demand for specialized immunization solutions, such as disaster relief, high-security facilities, and extreme weather environments.